(Q50110273)

English

Revealing the cost of Type II diabetes in Europe.

scientific article published on 24 May 2002

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12136405

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/12136405

title

Revealing the cost of Type II diabetes in Europe. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12136405

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/12136405

0 references

B Jönsson

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12136405

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/12136405

CODE-2 Advisory Board

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12136405

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/12136405

publication date

24 May 2002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12136405

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/12136405

published in

Diabetologia

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12136405

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/12136405

volume

45

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12136405

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/12136405

issue

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12136405

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/12136405

page(s)

S5-12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12136405

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/12136405

cites work

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00125-002-0858-X

retrieved

21 January 2018

Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00125-002-0858-X

retrieved

21 January 2018

Identifiers

DOI

10.1007/S00125-002-0858-X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12136405

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/12136405

PubMed publication ID

12136405

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12136405

retrieved

25 February 2018

reference URL

http://europepmc.org/abstract/MED/12136405

27942782

reason for deprecated rank

unchecked identifier

0 references

ResearchGate publication ID

11246295

0 references

(Q50110273)

Revealing the cost of Type II diabetes in Europe.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)